Background. Prophylactic antimicrobial therapy is frequently prescribed for acute aspiration pneumonitis, with the intent of preventing the development of aspiration pneumonia. However, few clinical ...
Phage therapy is a precision tool in the fight against antimicrobial resistance (AMR). Access, however, remains constrained by clinical and commercial integration, fragmented infrastructure, ...
Background.Outpatient parenteral antimicrobial therapy (OPAT) can be managed by specialists in infectious diseases (ID) or by other physicians. Better management of OPAT can reduce the likelihood of ...
Scientists Meet in Valencia to Define the Path to Clinical Integration Valencia, Spain. June 9–10, 2026 Researchers, clinicians, and biotechnology innovators from around the world will gather in ...
Clinicians should treat ventilator‑associated pneumonia (VAP) until the infection is controlled and the patient is clearly ...
The use of preventive measures and self-treatment for travelers' diarrhea is routine in regions where the occurrence of diarrhea is predictably high. People traveling to these areas who do not ...
Solenic Medical today announced the publication of new peer-reviewed research in Scientific Reports, a journal from Nature Portfolio, demonstrating that alternating magnetic fields (AMF) significantly ...
Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy How Should We Manage the Impact of Antimicrobial Resistance in Patients With Cancer? An Oncological and ...
Please provide your email address to receive an email when new articles are posted on . Provectus Biopharmaceuticals announced an exclusive worldwide license agreement with the University of Miami for ...
(Nanowerk Spotlight) Developing multifunctional nanomaterials has been a long-standing goal in the field of biomedical research. Over the years, scientists have explored various strategies to engineer ...
Nat Clin Pract Gastroenterol Hepatol. 2005;2(4):191-198. As antimicrobial resistance increases with more widespread use of these drugs, newer drugs with less potential for the development of ...